Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of Afimetoran in Participants With Active Systemic Lupus Erythematosus

NCT04895696 is registered in ClinicalTrials.gov with Beeline Medicines Corporation as lead sponsor.

NCT NCT04895696
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04895696 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of Afimetoran in Participants With Active Systemic Lupus Erythematosus
Lead sponsor
Beeline Medicines Corporation
Phase
Phase 2
Overall status
Active, not recruiting
Start date
October 11, 2021
Completion date
April 22, 2029
Enrollment
248 (actual)
Sites
147

Conditions

As the registry lists them; a condition with its own page is linked.

systemic lupus erythematosus